Form 4: Hims & Hers Health Chief Legal Officer Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., sold 2,339 shares of Class A Common Stock at $23.16 per share under a pre-arranged 10b5-1 trading plan.
Summary
- On October 29, 2024, Soleil Boughton, the Chief Legal Officer of Hims & Hers Health, Inc., sold 2,339 shares of Class A Common Stock.
- The sale was executed at a price of $23.16 per share.
- Following the transaction, Boughton directly owns 169,935 shares of Hims & Hers Health, Inc.
- The sale was conducted under a Rule 10b5-1 trading plan adopted on September 10, 2023.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction is a routine sale under a pre-arranged trading plan. It doesn't necessarily indicate a positive or negative outlook for the company.
Industry Context
Sales by company insiders are a common occurrence and are often viewed in the context of pre-arranged trading plans to avoid accusations of insider trading. The market typically assesses the volume and frequency of such sales to gauge potential impact.
Stakeholder Impact
- The sale could have a minor impact on shareholders if it creates downward pressure on the stock price, although the volume is relatively small.
- The impact on employees, customers, suppliers, and creditors is likely to be negligible.
Key Dates
| Date | Description |
|---|---|
| September 10, 2023 | Date the Rule 10b5-1 trading plan was adopted by Soleil Boughton. |
| October 29, 2024 | Date of the transaction (stock sale). |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.